Cover Image

Aberrant B-cell Subsets and Immunoglobulin Levels in Patients with Moderate-to-severe Psoriasis

Saved in:

Bibliographic Details
Main Authors:	Katrin Kahlert (Author), Franziska Grän (Author), Khalid Muhammad (Author), Sandrine Benoit (Author), Edgar Serfling (Author), Matthias Goebeler (Author), Andreas Kerstan (Author)
Format:	Book
Published:	Medical Journals Sweden, 2018-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anti-p200 Pemphigoid Mimicking Acquired Reactive Perforating Collagenosis
by: Janik Fleißner, et al.
Published: (2024)

Atypical Clinical and Serological Manifestation of Pemphigus Vegetans: A Case Report and Review of the Literature
by: Rebecca Mergler, et al.
Published: (2017)

Correlation of Immunoglobulin G With Severity Of Psoriasis
by: Rukhshan Khurshid, et al.
Published: (2023)

Concordance of adenosine deaminase with immunoglobulins and lymphocyte subsets in EBV-related diseases
by: Ting Shi, et al.
Published: (2023)

Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO)
by: Travaglini M, et al.
Published: (2023)

Age-related reference intervals for immunoglobulin levels and lymphocyte subsets in Indian children
by: Gaurav Narula, et al.
Published: (2017)

The effect of official competition on blood leucocyte subsets and serum immunoglobulins in male karateka
by: Abdolhossein Taheri Kalani, et al.
Published: (2019)

Structured Diagnostic Approach and Risk Assessment in Mucous Membrane Pemphigoid with Oesophageal Involvement
by: Sandrine Benoit, et al.
Published: (2018)

New therapeutic targets for the management of moderate-severe psoriasis
by: José C. Ruiz-Carrascosa, et al.
Published: (2022)

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
by: Gisondi P, et al.
Published: (2016)

Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review
by: Giampiero Girolomoni, et al.
Published: (2023)

Hidradenitis Suppurativa: Absence of Hyperhidrosis but Presence of a Proinflammatory Signature in Patients' Sweat
by: Verena G. Frings, et al.
Published: (2022)

Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption
by: Anna Campanati, et al.
Published: (2019)

Therapeutic Inertia in the Management of Moderate-to-Severe Plaque Psoriasis in Adolescents
by: Audrey Melin, et al.
Published: (2021)

Clinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
by: Light JG, et al.
Published: (2021)

Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
by: Ren V, et al.
Published: (2013)

Anticytokine therapy with interleukin-17 in patients with moderate and severe psoriasis
by: Julia S. Kovaleva, et al.
Published: (2024)

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
by: Sekhon S, et al.
Published: (2017)

Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis
by: Jin JQ, et al.
Published: (2023)

Disease severity in moderate‐to‐severe plaque psoriasis: Results from the Belgian REDISCOVER study
by: Tom Hillary, et al.
Published: (2024)

Transcriptomic Profiling of Plaque Psoriasis and Cutaneous T-Cell Subsets during Treatment with Secukinumab
by: Jared Liu, et al.
Published: (2022)

Thymopentapeptide Affects T-Cell Subsets by Modulating the Flora of the Skin Surface to Alleviate Psoriasis
by: Liu X, et al.
Published: (2024)

Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach
by: Monica Colombo, et al.
Published: (2020)

Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience
by: Rosés Gibert P, et al.
Published: (2022)

Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review
by: Pinter A, et al.
Published: (2019)

Clinical utility of secukinumab in moderate-to-severe scalp psoriasis: evidence to date
by: Kivelevitch D, et al.
Published: (2019)

Treatment of moderate‐to‐severe plaque psoriasis with tildrakizumab in the real‐life setting
by: Alessio Gambardella, et al.
Published: (2023)

Moderate to severe psoriasis treatment challenges through the era of biological drugs
by: Júlia Vide, et al.
Published: (2017)

Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
by: A. A. Kubanov, et al.
Published: (2019)

Seven cancer patients receiving Guselkumab for treatment of moderate-to-severe psoriasis
by: Luca Mastorino, et al.
Published: (2022)

Therapeutic response and survival time of immunobiologicals in patients with moderate to severe psoriasis
by: Cynthia Cristina Ferreira Mota, et al.
Published: (2022)

Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
by: Giovanna Malara, et al.
Published: (2021)

Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
by: Martina Burlando, et al.
Published: (2021)

Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics
by: Ruggiero A, et al.
Published: (2023)

Treatment of psoriasis vulgaris: guidelines of experts of the Polish Dermatological Society. Part II: moderate to severe psoriasis
by: Jacek Szepietowski, et al.
Published: (2014)

Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis
by: Alejandro Molina-Leyva, et al.
Published: (2015)

Bounded integer model‐based analysis of psoriasis area and severity index in patients with moderate‐to‐severe plaque psoriasis receiving BI 730357
by: Qing Xi Ooi, et al.
Published: (2023)

Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan
by: Yayoi Tada, et al.
Published: (2023)

Overexpressed immunoglobulin-like transcript (ILT) 4 in lung adenocarcinoma is correlated with immunosuppressive T cell subset infiltration and poor patient outcomes
by: Qing Li, et al.
Published: (2020)

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation
by: Néboa Zozaya, et al.
Published: (2022)